CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Forget Centessa Pharmaceuticals: This Rare-Disease Specialist Has a Superior Portfolio and Pipeline [Yahoo! Finance]
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Truist Financial Corporation from $33.00 to $38.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Avoro Capital Advisors LLC
Form 8-K Centessa Pharmaceuticals For: Feb 09
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
Form 4 Centessa Pharmaceuticals For: Feb 02 Filed by: Kanes Stephen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.